Hyperbaric Oxygen Therapy for Treatment of Severe Radiation-Induced Complications
Treatment of Radiation-Induced Complications With Hyperbaric Oxygen Therapy
1 other identifier
interventional
39
1 country
1
Brief Summary
This study evaluates the safety and effectiveness of hyperbaric oxygen therapy (HBOT) for the treatment of severe radiation-induced complications in patients previously treated with radiotherapy. Patients with clinically significant late radiation injuries will undergo HBOT sessions in a hyperbaric chamber. The study aims to assess clinical improvement of radiation damage and overall treatment tolerance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2016
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 19, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2019
CompletedFirst Submitted
Initial submission to the registry
February 11, 2026
CompletedFirst Posted
Study publicly available on registry
February 19, 2026
CompletedFebruary 19, 2026
February 1, 2026
3.6 years
February 11, 2026
February 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Reduction of severe radiation-induced tissue damage
Clinical Improvement of Radiation-Induced Complications After HBOT
Up to 3 months after completion of HBOT treatment
Study Arms (1)
Hyperbaric Oxygen Therapy (HBOT)
EXPERIMENTALPatients receiving hyperbaric oxygen therapy to treat severe radiation-induced complications and support tissue healing.
Interventions
Participants will undergo hyperbaric oxygen therapy sessions in a hyperbaric chamber, breathing 100% oxygen under increased atmospheric pressure, according to institutional protocol, to treat severe radiation-induced complications and support tissue healing.
Eligibility Criteria
You may qualify if:
- Adult patients (≥18 years)
- History of radiotherapy
- Clinically significant radiation-induced complications requiring hyperbaric oxygen therapy
- Ability to provide written informed consent
You may not qualify if:
- Contraindications to hyperbaric oxygen therapy (e.g., untreated pneumothorax)
- Severe comorbidity preventing safe HBOT treatment
- Inability to tolerate hyperbaric chamber sessions
- Withdrawal of informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institute of Oncology Ljubljana
Ljubljana, 1000, Slovenia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 11, 2026
First Posted
February 19, 2026
Study Start
May 19, 2016
Primary Completion
December 31, 2019
Study Completion
December 31, 2019
Last Updated
February 19, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share